Asset Management Ventures (AMV)


Asset Management Ventures (AMV) is a leading early-stage venture capital firm specializing in digital health, technology, and life sciences. With a rich history dating back to 1965, AMV has been at the forefront of innovation, helping founders build transformational companies. The firm leverages its extensive network and deep expertise in healthcare and technology to support entrepreneurs in creating groundbreaking solutions that address significant market opportunities.

Asset Management Ventures (AMV)

Asset Management Ventures (AMV)

1300 El Camino Real, Suite 100, Menlo Park, California 94025


What We Do

AMV provides strategic guidance and mentorship to its portfolio companies, helping them navigate challenges related to hiring, strategic focus, technical development, sales channels, and business partnerships.

AMV offers access to an unparalleled network of digital health stakeholders, aiding entrepreneurs in connecting with key industry players.

The firm takes an active role in assisting early-stage startups with operational challenges, leveraging its team's extensive operating experience as former entrepreneurs.


Investment Stage


Portfolio

Next-generation immunotherapy company

#Immunotherapy

Guiding people through their lifelong hormone journey

#Healthcare

An early pioneer in biotechnology, Amgen is one of the world’s largest independent biotechnology companies (NASDAQ:AMGN)

#Biotechnology

Developing and commercializing first-in-class therapy for substance use disorders

#Biopharmaceutical

Using cloud computation and deep learning to revolutionize medical imaging (acq. by Tempus)

#Medical Imaging

Innovative new gene therapy treatments for people with serious rare diseases (acq. by Astellas)

#Gene Therapy

AI copilots organize, contextualize and summarize unstructured data to improve patient outcomes

#AI in Healthcare

Leverages generative AI for smart, scalable prior authorization and utilization management for health plans

#Healthcare AI

Comprehensive solution to help employers save on health insurance (acq. by UnitedHealthcare)

#Health Insurance

Developing new therapies for neurological, autoimmune and hematological disorders (NASDAQ:BIIB)

#Biotechnology

Developer of PARP inhibitors as cancer therapies (acq. by Sanofi)

#Cancer Therapy

Utilizing AI on complex EMR data to empower clinicians

#Healthcare AI

Developing novel antiviral therapeutics (NASDAQ:CMRX)

#Pharmaceuticals

Molecular cardiology and drug discovery (acq. by Gilead Sciences)

#Cardiology

Provides innovative health insurance to self-employed individuals

#Health Insurance

Advancing heart health with customizable cardiovascular and metabolic health panels

#Cardiovascular Health

Developer of HDL therapies for cardiovascular and metabolic diseases (NASDAQ:ESPR)

#Cardiovascular

Captures and analyzes behavior data to quantify health outcomes

#Digital Health

Multiomics platform for early cancer detection using a routine blood draw

#Cancer Detection

Web and mobile-based interaction between physicians and patients

#Telemedicine

Online telepsychiatry platform connecting hospitals, doctors, clinics and patients (acq. by Genoa Healthcare)

#Telepsychiatry

Pioneering a novel approach of treating cardiovascular conditions by inhalation

#Cardiovascular

Developing synthetic diagnostic and therapeutic agents with antibody-like properties

#Diagnostics and Therapeutics

Producer of privacy software empowering the user to control personal data

#Privacy Software


Key People

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.